Medpace Inc. Expands Therapeutic Capabilities With the Acquisition of Pharma Brains AG, a European CRO With Global Experience in Oncology Drug Development
clinical research medpace
CINCINNATI, OH–(Marketwire – Nov 2, 2009) – Medpace, a secretly held, global
full-service clinical investigate organization, currently voiced it has
entered in to a squeeze agreement to take Pharma Brains AG, an oncology
focused CRO formed in Basel, Switzerland.
Pharma Brains is an glorious fit with Medpace in conditions of its
complementary healing expertise, clever care and competent staff.
Pharma Brains is led by Dr. Marc Salzberg, President and CEO, a research
professional with endless knowledge in oncology Phase I-IV studies as good as drug growth and
regulatory affairs.
“I am gratified to have Dr. Salzberg fasten the organisation as an constituent leader
beginning with the formation and going brazen as the VP of Oncology,
Europe and General Manager, Switzerland,” pronounced Dr. Aug Troendle,
President and CEO, Medpace. “Marc Salzberg is a renowned professional
in European drug growth and brings seventeen years of attention and leadership
experience to Medpace.”
The formation of Pharma Brains operations will proceed rught away with the
intent of completing the partnership by the finish of 2009.
ABOUT MEDPACE
Medpace is a heading tellurian full-service clinical investigate organization
providing Phase I-IV core growth services for drug, biologic, and
device programs. With healing and regulatory imagination in mixed therapeutic
specialties, Medpace has fabricated the industry’s many gifted and
therapeutically focused teams to govern at each turn of the company’s
operations, on condition that finish and seamless drug growth services. In
June 2009 Medpace was rated as the many appropriate CRO by U.S. Investigators in the
2009 CenterWatch Site Survey.
Medpace creates vital partnerships with curative and
biotechnology companies to yield the many fit and cost-effective
path to drug growth — from module formulation and execution to product
approval.
With some-more than 1000 employees and clinical hearing knowledge in over 30
countries, Medpace has the tellurian strech and capacity to control studies
and navigate regulatory mandate worldwide. In further to Phase II-IV
development services, Medpace provides: Phase I / IIA clinical services
from Medpace Clinical Pharmacology, executive laboratory and therapeutically
specialized contrast from Medpace Reference Laboratories, complete
bioanalytical services in all stages of drug growth from Medpace
Bioanalytical Laboratories, and executive picture government and celebration of the mass from
Imagepace.
ABOUT PHARMA BRAINS AG
Founded in 1995, Pharma Brains operates as a secretly hold shareholder
company headquartered in the biovalley of Basel, Switzerland. Pharma Brains
is specialized in the areas of oncology and cardiology. Pharma Brains
staff is informed with investigate and growth of classical
pharmaceuticals, biotech products and healing devices.
Visit the Medpace website at www.medpace.com
